Transmyocardial CO2 laser revascularization improves symptoms, function, and quality of life: 12-month results from a randomized controlled trial

[1]  L. Hillis,et al.  Transmyocardial laser revascularization. , 1999, The New England journal of medicine.

[2]  O. Frazier,et al.  Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. , 1999, The New England journal of medicine.

[3]  Robert D. Dowling,et al.  Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. , 1999, The New England journal of medicine.

[4]  Daniel Burkhoff,et al.  Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial , 1999, The Lancet.

[5]  M. Leon,et al.  Current perspectives on direct myocardial revascularization. , 1998, The American journal of cardiology.

[6]  B P Griffith,et al.  Transmyocardial laser revascularization: results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease. , 1997, The Journal of thoracic and cardiovascular surgery.

[7]  D. Burkhoff,et al.  Histologic appearance of transmyocardial laser channels after 4 1/2 weeks. , 1996, The Annals of thoracic surgery.

[8]  D. Burkhoff,et al.  Does blood flow through holmium:YAG transmyocardial laser channels? , 1996, The Annals of thoracic surgery.

[9]  W H Rogers,et al.  Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. , 1995, Medical care.

[10]  R A Deyo,et al.  Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. , 1995, Journal of the American College of Cardiology.

[11]  J. Spertus,et al.  Monitoring the quality of life in patients with coronary artery disease. , 1994, The American journal of cardiology.

[12]  R. Tibshirani,et al.  An Introduction to the Bootstrap , 1995 .

[13]  G H Guyatt,et al.  USERS' GUIDES TO THE MEDICAL LITERATURE. II: HOW TO USE AN ARTICLE ABOUT THERAPY OR PREVENTION A. ARE THE RESULTS OF THE STUDY VALID ? , 1993 .

[14]  C. McHorney,et al.  The MOS 36‐Item Short‐Form Health Survey (SF‐36): II. Psychometric and Clinical Tests of Validity in Measuring Physical and Mental Health Constructs , 1993, Medical care.

[15]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[16]  A. Stewart,et al.  The MOS short-form general health survey. Reliability and validity in a patient population. , 1988, Medical care.

[17]  B. Spilker,et al.  Quality of life and pharmacoeconomics in clinical trials , 1996 .

[18]  Gordon H. Guyatt,et al.  How to Use an Article About Therapy or Prevention , 1995 .

[19]  D. Cooley,et al.  Transmyocardial laser revascularization. Anatomic evidence of long-term channel patency. , 1994, Texas Heart Institute journal.

[20]  G. Guyatt,et al.  Users' guides to the medical literature. , 1993, JAMA.